| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/03/1997 | WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | WO1997018232A3 Peptides derived from the oncogene proteine bcr-abl expressed by leukemic cells and utilisation thereof for the therapy of human leukemiae |
| 07/03/1997 | CA2241023A1 Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/03/1997 | CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | CA2239682A1 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2213512A1 Method for producing bioactive fusion protein |
| 07/02/1997 | EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases |
| 07/02/1997 | EP0781343A1 Retroviral vector hybrids and the use thereof for gene transfer |
| 07/02/1997 | EP0781336A1 A human map kinase homolog |
| 07/02/1997 | EP0781333A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 07/02/1997 | EP0781332A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 07/02/1997 | EP0781331A1 Improvements in or relating to binding proteins for recognition of dna |
| 07/02/1997 | EP0781326A1 The irs family of genes |
| 07/02/1997 | EP0781092A1 Method of sensitizing tumor cells with adenovirus e1a |
| 07/02/1997 | EP0575350A4 Method for culturing and transforming human stem cell-containing compositions |
| 07/02/1997 | EP0544713B1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 07/01/1997 | US5643788 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 07/01/1997 | US5643785 Polynucleotides encoding AMPA-binding human GluR4 receptors |
| 07/01/1997 | US5643778 RNA editing enzyme and methods of use thereof |
| 07/01/1997 | US5643770 Retroviral vector particles expressing complement inhibitor activity |
| 07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
| 07/01/1997 | US5643746 Human epidermal gene promoter |
| 07/01/1997 | US5643578 Subunit vaccines |
| 07/01/1997 | US5643567 Antigrowth agents for tumors |
| 06/26/1997 | WO1997022722A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/26/1997 | WO1997022709A1 Host adaptation of retroviral vectors |
| 06/26/1997 | WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 06/26/1997 | WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
| 06/26/1997 | WO1997022696A1 Utrophin gene expression |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022689A1 Chromosome 13-linked breast cancer susceptibility gene |
| 06/26/1997 | WO1997022623A1 Osteo antiviral protein |
| 06/26/1997 | WO1997022363A2 Improved pharmaceutical compositions |
| 06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
| 06/26/1997 | WO1997020045A3 P2u2 purinergic receptor |
| 06/26/1997 | WO1997011190A3 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy |
| 06/26/1997 | WO1997010005A3 Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| 06/26/1997 | WO1997007225A3 High efficiency retroviral packaging system |
| 06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
| 06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 06/26/1997 | CA2241371A1 Genetic suppressor elements against human immunodeficiency virus |
| 06/26/1997 | CA2241040A1 Improved pharmaceutical compositions |
| 06/26/1997 | CA2240938A1 Utrophin gene expression |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2239783A1 Host adaptation of retroviral vectors |
| 06/26/1997 | CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto |
| 06/25/1997 | EP0780475A1 CDNA corresponding to the genome of negative-strand RNA viruses, and process for the production of infectious negative-strand RNA viruses |
| 06/25/1997 | EP0779929A1 Non self-inactivating, expression targeted retroviral vectors |
| 06/25/1997 | EP0779922A2 Modified human c3 proteins |
| 06/25/1997 | EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 06/25/1997 | CN1152938A Growth control for cells encapsulated within bioartificial organs |
| 06/25/1997 | CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 06/25/1997 | CN1152875A Enhanced virus-mediated DNA transfer |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
| 06/24/1997 | US5641754 Antitumor agents |
| 06/24/1997 | US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| 06/24/1997 | US5641680 For gene therapy treatment |
| 06/24/1997 | US5641670 Protein production and protein delivery |
| 06/24/1997 | US5641665 Plasmids suitable for IL-2 expression |
| 06/24/1997 | US5641662 Transfection of lung via aerosolized transgene delivery |
| 06/24/1997 | US5641657 DNA encoding an interleukin-6 splice variant |
| 06/24/1997 | US5641625 Peptide nucleic acids forming duplex, triplex and other structures with nucleic acids; modulation of protein activity by transcription arrest and initiation; specific site cleavage |
| 06/24/1997 | US5641508 Method for delivering melanin to hair follicles |
| 06/24/1997 | US5641484 Introducing to tumor either vector comprising nucleic acid encoding simian virus antigen gene product linked to promoter or liposome complexed to said nucleic acid, wherein production of gene product suppresses tumor growth |
| 06/19/1997 | WO1997021826A2 Complementary adenoviral vector systems and cell lines |
| 06/19/1997 | WO1997021825A1 Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| 06/19/1997 | WO1997021819A1 Novel nagpu |
| 06/19/1997 | WO1997021811A2 Novel tyrosine kinase receptors and ligands |
| 06/19/1997 | WO1997021809A1 Dna sequence encoding the tumor suppressor ing1 |
| 06/19/1997 | WO1997021808A1 Modified vegf antisense oligonucleotides |
| 06/19/1997 | WO1997017434A3 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 06/19/1997 | WO1997016221A3 Genetic induction of receptors for targeted radiotherapy |
| 06/19/1997 | WO1997012986A3 Non-group c adenoviral vectors |
| 06/19/1997 | WO1997010796A3 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
| 06/19/1997 | WO1997006662A3 Inverted chimeric and hybrid oligonucleotides |
| 06/19/1997 | CA2239993A1 Dna sequence encoding the tumor suppressor ing1 |
| 06/19/1997 | CA2239991A1 Modified vegf antisense oligonucleotides |
| 06/18/1997 | EP0779365A2 Methods to introduce nucleic acid into cells for therapeutic and diagnostic uses |
| 06/18/1997 | EP0778889A2 Recombinant adenovirus comprising a chimeric penton base protein |
| 06/18/1997 | EP0778842A1 Mammalian telomerase |
| 06/18/1997 | CN1152337A Superoxide dismutase-4 |
| 06/18/1997 | CN1152251A Isolated nucleic acid sequence coding for a tumor rejection antigen presented by HLA-A2 |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/17/1997 | US5639661 Genes and proteins for treating cystic fibrosis |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639651 Gap-related gene, human IQGAP1 |
| 06/17/1997 | US5639647 2'-deoxy-2'alkylnucleotide containing nucleic acid |
| 06/17/1997 | US5639505 Applying a glassy carbohydrate film containing sugars and an allosteric effector on the substrate; reduced surface energy |
| 06/17/1997 | US5639275 Capsule containing genetically engineered cells |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2192738A1 Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/12/1997 | WO1997020935A2 Viral vectors |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |